Integrating GLP-1 Weight Loss Protocols into MedSpa Operations

We are seeing a massive shift in patient acquisition costs as GLP-1 weight loss protocols become the primary entry point for new medical spa clients. While the demand for semaglutide and tirzepatide is undeniable, we must approach these programs with the rigor of a clinical practice rather than a retail transaction. We focus heavily on the initial metabolic screening and the long-term titration schedule to mitigate common side effects like delayed gastric emptying. From an operational standpoint, we recommend bundling these injections with body contouring treatments or skin tightening services to address the tissue laxity that often follows rapid weight loss. Maintaining a reliable compounding pharmacy relationship or a direct wholesale account is critical for inventory stability. We believe that by positioning weight loss as a comprehensive wellness journey rather than a quick fix, we secure higher patient retention and build a more sustainable recurring revenue model for our facilities.